In addition, NOX4 is also one of the marker genes of immune infiltration, and is highly correlated with the prediction of gastric cancer immunotherapy (Xin et al., 2022), the pathogenesis of keloid disorder (Yin et al., 2022), and the clinical outcome of colon cancer (Yang et al., 2020). Here, NOX4 is linked to malignant colon neoplasm.